Palomar v. Alma Lasers
This article was originally published in The Gray Sheet
Alma will pay royalties on past and future sales of its light-based hair removal systems to resolve patent infringement charges filed by Palomar in Massachusetts federal court. Palomar accused Alma's Harmony, Soprano, Soprano XL andSonata systems of infringing its '844 and '568 patents. "After a nine-month period at a slightly higher rate, Alma Lasers will pay a 7.5% ongoing royalty rate," Alma says. The firm also has agreed to change the appearance of its Harmony and Aria systems to avoid confusion with Palomar systems and will pay 11% for past patent and trade dress infringement. Cutera and Lumenis have settled similar cases with Palomar (1"The Gray Sheet" June 12, 2006, p. 12)...
You may also be interested in...
Palomar plans to enforce its Anderson patents against additional makers of laser and lamp-based hair removal systems following a successful settlement June 5 with competitor Cutera for $22 mil. plus royalties
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.